Abstract
Objectives
We compared the concentrations of the proinflammatory cytokine interleukin-2 (IL-2) with the anti-inflammatory cytokine interleukin-10 (IL-10) in serial serum samples from improved and expired acute ischemic stroke (AIS) patients to determine their prognostic usefulness.
Materials and methods
Blood from AIS patients (n = 17) admitted within 24 h of the onset of symptoms were collected at admission and 24, 48, 72, and 144 h after admission. Pro- and anti-inflammatory cytokines were measured by enzyme-linked immunosorbant assay.
Results
IL-2 levels were elevated in serum samples from AIS patients collected at 0 (0.97, P < 0.01) and 24 h (1.011, P < 0.01). IL-2 concentrations gradually decreased at subsequent time-points (48, 72, and 144 h samples, 0.324, P < 0.05) in patients who improved (n = 13), but not in those who expired (n = 4). Similarly, a decrease in IL-10 levels was observed in serum samples from AIS patients who improved at 24 h (0.180, P < 0.05), followed by significant increases at 72 h (0.97, P < 0.01 vs. control) and 144 h (1.38, P < 0.01).
Conclusion
The levels of IL-2 and IL-10 correlate well with outcome in AIS patients and may be useful in prognosis.
Similar content being viewed by others
References
Dalal PM, Madhumita B. Stroke epidemic in India: hypertension-stroke control programme is urgently needed. J Assoc Physicians India. 2007;55:689–91.
Dalal PM. Burden of stroke: Indian perspective. J Assoc Physicians India. 2004;52:695–6.
Banerjee TK, Das SK. Epidemiology of stroke in India. Neurol Asia. 2006;11:1–4.
Beamer NB, Coull BM, Clark WM, Hazel JS, Silberger JR. Interleukin-6 and interleukin-1 receptor antagonist in acute stroke. Ann Neurol. 1995;37:0–04.
Fassbender K, Rossol S, Kammer T, Daffertshofer M, Wirth S, Dollman M, et al. Proinflammatory cytokines in serum of patients with acute cerebral ischemia: kinetics of secretion and relation to the extent of brain damage and outcome of disease. J Neurol Sci. 1994;22:135–9.
Chamoro A. Role of inflammation in stroke and atherothrombosis. Cerebrovasc Dis. 2004;17:1–5.
Pantoni L, Sarti C, Inzitari D. Cytokines and cell adhesion molecules in cerebral ischemia. Experimental bases and therapeutic perspectives. Arterioscler Thromb Vasc Biol. 1998;18:503–13.
Del Zoppo G, Ginis I, Hallenbeck JM, Iadecola C, Wang X, Feuerstein GZ. Inflammation and stroke: putative role for cytokines, adhesion molecules and iNOS in brain response to ischemia. Brain Pathol. 2000;10:95–112.
Waje-Andreassen U, Krakenes J, Ulvestad E, Thomassen L, Myhr KM, Aarseth J, et al. IL-6: an early marker for outcome in acute ischemic stroke. Acta Neurol Scand. 2005;111:360–5.
Mazzotta G, Sarchielli P, Caso V, Paciaroni M, Floridi A, Floridi A, et al. Different cytokine levels in thrombolysis patients as predictors for clinical outcome. Eur J Neurol. 2004;11:377–81.
Suzuki S, Tanaka K, Nogawa S, Nagata E, Ito D, Dembo T, et al. Temporal profile and cellular localization of interleukin-6 protein after focal cerebral ischemia in rats. J Cereb Blood Flow Metab. 1999;19:1256–62.
Liu T, Clark RK, McDonnell PC, Young PR, White RF, Barone FC, et al. Tumor necrosis factor-alpha expression in ischemic neurons. Stroke. 1994;25:1481–8.
Sairanen T, Carpén O, Karjalainen-Lindsberg ML, Paetau A, Turpeinen U, Kaste M, et al. Evolution of cerebral tumor necrosis factor-alpha production during human ischemic stroke. Stroke. 2001;32:1750–8.
Han HS, Yenari MA. Cellular targets of brain inflammation in stroke. Curr Opin Investing Drugs. 2003;4:522–9.
Zhai QH, Futrell N, Chen FJ. Gene expression of IL-10 in relationship to TNF-alpha, IL-1beta and IL-2 in the rat brain following middle cerebral artery occlusion. Journal of Neurological Sciences. 1997;152:119–24.
Van Exel E, Gussekloo J, de Craen AJ, Bootsma-van der Wiel A, Frölich M, Westendorp RG. Inflammation and stroke: the Leiden 85-Plus Study. Stroke. 2002;33:1135–8.
Alison EB. The forgotten lymphocyte: immunity and stroke. Circulation. 2006;113:2035–6.
Spera PA, Ellison JA, Feuerstein GZ, Barone FC. IL-10 reduces rat brain injury following focal stroke. Neurosci Lett. 1998;251:189–92.
Rosenstein M, Ettinghausen SE, Rosenberg SA. Extravasation of intravascular fluid mediated by the systemic administration of recombinant interleukin 2. J Immunol. 1986;137:1735–42.
Ellison MD, Krieg RJ, Povlishock JT. Differential central nervous system responses following single and multiple recombinant interleukin-2 infusions. J Neuroimmunol. 1990;28:249–60.
Chamorro A, Vila N, Ascaso C, Saiz A, Montalvo J, Alonso P, et al. Early prediction of stroke severity: role of the erythrocyte sedimentation rate. Stroke. 1995;26:573–6.
Pullicino PM, Alexandrov AV, Shelton JA, Alexandrova NA, Smurawska LT, Norris JW. Mass effect and death from severe acute stroke. Neurology. 1997;49:1090–5.
Acknowledgment
We thank Mr. Prashant Deoras for assistance in statistical analyses.
Author information
Authors and Affiliations
Corresponding author
Additional information
Responsible Editor: A. Bauhofer.
Rights and permissions
About this article
Cite this article
Nayak, A.R., Kashyap, R.S., Purohit, H.J. et al. Evaluation of the inflammatory response in sera from acute ischemic stroke patients by measurement of IL-2 and IL-10. Inflamm. Res. 58, 687–691 (2009). https://doi.org/10.1007/s00011-009-0036-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00011-009-0036-4